Three-year outcomes of a phase II study of adjuvant chemotherapy with S-1 plus docetaxel for stage III gastric cancer after curative D2 gastrectomy

By Fujitani Kazumasa   Tamura Shigeyuki   Kimura Yutaka   Tsuji Takeshi   Matsuyama Jin   Iijima Shohei   Imamura Hiroshi   Inoue Kentaro   Kobayashi Kenji   Kurokawa Yukinori   Shimokawa Toshio   Tsujinaka Toshimasa   Furukawa Hiroshi  

Gastric Cancer, Vol. 17, Iss. 2, 2014-04 ,pp. : 348-353

Springer Publishing Company

Access to resources Recommend Favorite

Macroscopic tumor size as an independent prognostic factor for stage II/III gastric cancer patients who underwent D2 gastrectomy followed by adjuvant chemotherapy with S-1

By Aoyama Toru  

Gastric Cancer, Vol. 14, Iss. 3, 2011-08 ,pp. : 274-278

Springer Publishing Company

Access to resources Recommend Favorite

Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials

By Earle C.C.   Maroun J.A.  

European Journal of Cancer, Vol. 35, Iss. 7, 1999-07 ,pp. : 1059-1064

Elsevier

Access to resources Recommend Favorite

Impact of chemotherapy-related prognostic factors on long-term survival in patients with stage III colorectal cancer after curative resection

By Tsai Wen-Sy  

International Journal of Clinical Oncology, Vol. 18, Iss. 2, 2013-04 ,pp. : 242-253

Springer Publishing Company

Access to resources Recommend Favorite

Survival analysis of adjuvant chemotherapy with S-1 plus cisplatin for stage III gastric cancer

By Takahari Daisuke   Hamaguchi Tetsuya   Yoshimura Kenichi   Katai Hitoshi   Ito Seiji   Fuse Nozomu   Konishi Masaru   Yasui Hirofumi   Terashima Masanori   Goto Masahiro   Tanigawa Nobuhiko   Shirao Kuniaki   Sano Takeshi   Sasako Mitsuru  

Gastric Cancer, Vol. 17, Iss. 2, 2014-04 ,pp. : 383-386

Springer Publishing Company

Access to resources Recommend Favorite